Rebalix
Vanguard · sheet of 5 September 2026
Vanguard · sheet of 5 September 2026ETF sheet · official issuer and register data
Vanguard ESG EUR Corporate Bond UCITS ETF (EUR) Accumulating
V3RE · IE000QADMYA3 · EUR · domicile Ireland
Bonds · Corporate EUR · Broad (all maturities) · GlobalSFDR art. 8
Index tracked: Bloomberg MSCI EUR Corporate Liquid Bond Screened Index
- TER
- 0.09%+ trans. 0.10%
- Fund size
- 133 m EUR
- Tracking difference
- −0.11%3-year avg
- 🇮🇹 tax rate
- 26.00%white list 0.00%
- Replication
- Physical (sampled)
- Income
- Accumulating
- Duration
- 4.50 yrsmedium (3–7 years)
Launch 15 Nov 2022 · costs from the KID as of 2 Sept 2026 · 1,149 securities held · 11 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
The Fund employs a passive management – or indexing – investment approach, through physical acquisition of securities, and seeks to track the performance of the Bloomberg MSCI EUR Corporate Liquid Bond Screened Index (the “Index”). In tracking the performance of the Index, the Fund will invest in a EUR denominated portfolio of investment grade corporate fixed-rate bonds that so far as possible and practicable consists of a representative sample of the component securities of the Index. The Index is constructed from the Bloomberg Euro-Aggregate Corporate…
Performance since series start (in euro) — base 100
31 Dec 2022 → 31 Jul 2026 · dividends reinvested where declared by the issuer
Returns in euro
| 1 year | +1.4% |
| 3 years | +13.0% |
| 5 years | series too young |
| 10 years | series too young |
| Since series start | +16.5% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 2.76% | 2.97% | — |
| Max drawdown | −2.63% | −2.63% | — |
| Sharpe | -0.56 | 0.27 | — |
| Sortino | -0.81 | 0.39 | — |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · V3RE · IE000QADMYA31
RebalixV3RE · IE000QADMYA3 · sheet of 5 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · from issuer-declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +2.93% | +2.98% | −0.06% |
| 2024 | +4.56% | +4.71% | −0.14% |
| 2023 | +7.96% | +8.09% | −0.13% |
Fixed income — as declared by the issuer
Factsheet · 31 Jul 2026 · investment-grade share (BBB−/Baa3 and above): 99.2%
Rating breakdown (% of fund)
Maturity breakdown (% of fund)
Holdings
Portfolio as declared by the issuer · 31 Jul 2026 · 1,149 securities · top-10 weight = 2.8%
Countries (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
V3RE · Borsa Italiana (ETFplus), Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Euronext Amsterdam, Tradegate Exchange, Xetra (Deutsche Börse)
— · Euronext Paris
+ 13 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
Prospectus · fund-docs.vanguard.com/etf-prospectus-en.pdf
The live sheet, always up to date
rebalix.com/en/etf/IE000QADMYA3
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE000QADMYA3
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · V3RE · IE000QADMYA32